Early myeloma drug trial yields hope
A new myeloma drug shows promising early trial results, offering hope for patients resistant to current treatments.
A new myeloma drug shows promising early trial results, offering hope for patients resistant to current treatments.
Mastocytosis patients face unique dental challenges due to potential reactions to medications like epinephrine in local anesthetics.
The new ASH guidelines transform AYA ALL care by recommending pediatric‑inspired chemotherapy, boosting survival for patients aged 15‑39…
Learn how mastocytosis triggers can be tracked by logging symptoms, meals and stress, enabling patients to craft a…
Discover how lung cancer screening with low‑dose CT can dramatically improve survival rates, offering early detection benefits for…
Discover the latest breakthroughs in advanced breast cancer treatment, improving care for HR+/HER2- patients with tailored therapies.